MentalHealthDaily

Restless Legs: Striatal Dopamine-Opioid Hypersensitivity

by GLOOM

Restless legs syndrome (RLS) and opioid-withdrawal restlessness both produce night-worsening urges to move. A 2026 npj Parkinson’s Disease mouse study tied that overlap to hypersensitive striatal D1-mu-opioid receptor signaling in basal-ganglia motor circuits.1 Research Highlights 2 clinically similar states converged: restless legs syndrome and opioid-withdrawal restlessness both point toward a striatal D1-mu-opioid circuit that regulates …

Human Substantia Nigra Neurons Tracked Prior Reward and Faster Motivation

by GLOOM

MHD featured image for substantia nigra dopamine reward-history signals.

A 2026 iScience study recorded 27 substantia nigra neurons during deep-brain-stimulation surgery in 11 Parkinson’s disease patients and found that prior reward shaped both putative dopamine-neuron firing and the next reaction time: responses were faster after a +$10 outcome than after neutral or negative outcomes (0.916 s vs. 1.017 s, p = 0.0175).1 Research Highlights …

Parkinson’s Metabolite Biomarkers Split 3 Patient Groups

by GLOOM

MHD featured image for Parkinson's disease metabolite biomarkers and patient metabolic subgroups.

A 2026 Parkinson’s disease study used gene-expression data and genome-scale metabolic modeling to predict patient-level metabolite patterns, then separated 104 patients into 3 metabolic subgroups that were partly reproduced in an independent 81-patient validation dataset. Research Highlights Patient-level modeling found heterogeneity: Abdik et al. predicted secretion tendencies for 802 analyzable metabolites across 104 postmortem substantia …

Chronic Stress Increased Mouse D1 and D2 Dopamine Receptors

by GLOOM

Stylized striatal dopamine receptor map in a mouse stress model, highlighting widespread D1 receptor binding increases and selective D2 changes after chronic mild stress.

Chronic stress is a candidate mechanism for both depression and addiction risk. A 2026 mouse study found that 28 days of unpredictable chronic mild stress increased striatal dopamine D1 receptor binding by 22–48% across nearly every region examined, plus more selective D2 receptor increases — pointing to a stress-driven shift in reward signaling that may …

GLP-1 Drugs Suppress Reward Feeding Through an Amygdala-Dopamine Circuit

by GLOOM

MHD featured image for GLP-1 drugs, reward feeding, amygdala signaling, and dopamine circuitry.

GLP-1 drugs are usually described as appetite drugs, but a 2026 Nature mouse study mapped a more specific reward circuit: small-molecule GLP-1 receptor agonists suppressed palatable-food intake through Glp1r-expressing central-amygdala neurons that reduced dopamine release in the nucleus accumbens during high-fat-food retrieval.1 That mechanism makes binge-eating and substance-use hypotheses more plausible without turning an animal …

GABA and Dopamine Shape Human Speech Control in PET-fMRI Study

by GLOOM

MHD featured image for GABA and dopamine interactions during human speech control.

A 2026 PET-fMRI study of 20 healthy adults found that GABAA receptor binding tracked speech-production brain activity across frontal, temporal, parietal, putaminal, supplementary motor, and cerebellar regions, with peak GABA-BOLD correlations reaching Rs = 0.9.1 Human speech control looks less like a pure motor-output problem and more like a task-specific balance between inhibition, dopamine, and …

Semaglutide Reduced Cocaine Choice in Rat Study

by GLOOM

Semaglutide is not close to being an approved cocaine-use-disorder medication, but a 2026 rat study gives the idea a more demanding preclinical test than ordinary self-administration experiments. After 5 days of treatment, rats shifted away from cocaine choice without losing total operant responding, which separates the result from a broad appetite-suppression artifact. Research Highlights Semaglutide …